Date: 30 Jan 2020 17:00-20:30 (UK)
Location: London, UK
Commemorate the 8th anniversary of the London Declaration on NTDs by joining the London Centre for Neglected Tropical Disease Research (LCNTDR) for an evening of presentations and discussion.
This networking event will shine a spotlight on the pivotal role that NTD research plays in shaping new approaches and frameworks to controlling and eliminating NTDs. Quickfire presentations will highlight some of the new innovations and approaches that will be shaping future public health approaches.
The London Centre for Neglected Tropical Disease Research is an innovative research collaboration between Imperial College London, the London School of Hygiene & Tropical Medicine, the Royal Veterinary College, and the Natural History Museum, to bring together leading experts to tackle diseases which affect the lives of over 1.7 billion of the poorest people across the globe.
Featuring rapid presentations:
- Validation of a recombinase polymerase amplification assay for the diagnosis of female genital schistosomiasis in Zambian women using cervicovaginal lavage and vaginal self-swab samples (John Archer, NHM)
- Estimating the economic impact of schistosomiasis in ruminants in Senegal (Barbara Haesler, RVC)
- The risk of Severe Adverse Events associated with ivermectin distribution in areas co-endemic for onchocerciasis and loiasis: a mathematical modelling study using EPILOA, (Charlie Whittaker, Imperial)
- Accelerating trachoma elimination through ‘Stronger-SAFE’ (Ailie Robinson, LSHTM)
- Achieving and sustaining elimination of schistosomiasis and soil-transmitted helminths: the Geshiyaro Project (Anna Phillips, Imperial)
- Skin Health Africa Research Programme (SHARP) (Steve Walker, LSHTM)
- Micro-CT visualisation of the parasite-host interface in sandflies and blackflies, (Martin Hall, NHM)
- Schistosomiasis – assessing progress towards the 2020 and 2025 goals (Arminder Deol, LSHTM/RVC)
- Elimination of Onchocerciasis: The case for Moxidectin (Martin Walker, Imperial)
- Defining a prevalence level to describe the elimination of Lymphatic Filariasis transmission (Benjamin Collyer, Imperial)
- Patterns of individual non-treatment during multiple rounds of community-wide mass drug administration for control of soil-transmitted helminths in the TUMIKIA trial, Kenya (Will Oswald, LSHTM)
- Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination (Klodeta Kura, Imperial)
- Towards the 2030 goals for Chagas disease: incidence and prevalence trends for 15 Latin American countries (Zulma M. Cucunubá, Imperial)
- Morbidity control in schistosomiasis hotspots - an introduction to the FibroScHot trial protocol (Shona Wilson, RVC/Cambridge)
For more details, or to register, visit the event webpage.